Jun. 24, 2013
Rank
|
product
|
number
|
Earliest registration (year)
|
Latest
registration (year)
|
1
|
thiram·carbofuran
|
43
|
2008
|
2009
|
2
|
tebuconazole
|
30
|
2005
|
2012
|
3
|
carbendazim·thiram·carbofuran
|
28
|
2008
|
2009
|
4
|
imidacloprid
|
23
|
2004
|
2012
|
5
|
carbendazim·thiram
|
21
|
2008
|
2012
|
6
|
carbosulfan
|
11
|
1999
|
2012
|
7
|
thiram·amicarthiazol
|
9
|
2007
|
2012
|
8
|
carbofuran·carbendazim
|
9
|
2008
|
2009
|
9
|
phorate·carbofuran
|
8
|
2008
|
2009
|
10
|
tebuconazole·thiram
|
7
|
2009
|
2012
|
Source: ICAMA
|
More seed treatment registrations have been applied and are in the process of field trials. It is estimated that the number of registration of seed treatment will double to some 700 in the coming two to three years.
As per statistics, the most popular products applied for registration are Imidacloprid, Thiamethoxam, Difenoconazole, Tebuconazole, Fipronil, among which, Thiamethoxam is a star product owing to its wide spectrum efficiency and low toxicity.
Figure 1: Application numbers of Top 5 products in year 2010, 2011, 2012
Subscribe Email: | * | |
Name: | ||
Mobile Number: | ||
0/1200